Muscle wasting in cardiac cachexia

被引:80
作者
Strassburg, S
Springer, J
Anker, SD
机构
[1] Charite, Dept Cardiol, Div Appl Cachexia Res, D-13353 Berlin, Germany
[2] Univ London Imperial Coll Sci & Technol, NHLI, Dept Clin Cardiol, London, England
关键词
muscle; cachexia; wasting; chronic heart failure;
D O I
10.1016/j.biocel.2005.03.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cardiac cachexia is a serious complication of chronic heart failure which is characterized by complex changes that overall lead to a catabolic/anabolic imbalance resulting in body wasting and a poor prognosis. The wasting process affects all body components, but particularly the skeletal musculature, causing extreme fatigue and weakness, especially in cachectic heart failure patients. Available evidence suggests that several pathophysiologic pathways play a role in the muscle wasting process. Metabolic, neurohormonal, and immune abnormalities lead to an altered regulation of proliferation, differentiation, apoptosis, and metabolism in skeletal muscle, finally resulting in deterioration of the underlying cause with symptomatic exercise intolerance. Possible treatment strategies against muscle wasting and cachexia in chronic heart failure are also described here. As there is no validated therapy for cardiac cachexia yet, further research is necessary to find more therapeutic options for the wasting process. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1938 / 1947
页数:10
相关论文
共 87 条
[11]   Cardiac cachexia - A syndrome with impaired survival and immune and neuroendocrine activation [J].
Anker, SD ;
Coats, AJS .
CHEST, 1999, 115 (03) :836-847
[12]   Wasting as independent risk factor for mortality in chronic heart failure [J].
Anker, SD ;
Ponikowski, P ;
Varney, S ;
Chua, TP ;
Clark, AL ;
WebbPeploe, KM ;
Harrington, D ;
Kox, WJ ;
PooleWilson, PA ;
Coats, AJS .
LANCET, 1997, 349 (9058) :1050-1053
[13]   Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone [J].
Anker, SD ;
Volterrani, M ;
Pflaum, CD ;
Strasburger, CJ ;
Osterziel, KJ ;
Doehner, W ;
Ranke, MB ;
Poole-Wilson, PA ;
Giustina, A ;
Dietz, R ;
Coats, AJS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :443-452
[14]   Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function [J].
Barton-Davis, ER ;
Shoturma, DI ;
Musaro, A ;
Rosenthal, N ;
Sweeney, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) :15603-15607
[15]   LOW-INTENSITY EXERCISE TRAINING IN PATIENTS WITH CHRONIC HEART-FAILURE [J].
BELARDINELLI, R ;
GEORGIOU, D ;
SCOCCO, V ;
BARSTOW, TJ ;
PURCARO, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (04) :975-982
[16]  
BELCH JJF, 1991, BRIT HEART J, V65, P245
[17]   Functional improvement of dystrophic muscle by myostatin blockade [J].
Bogdanovich, S ;
Krag, TOB ;
Barton, ER ;
Morris, LD ;
Whittemore, LA ;
Ahima, RS ;
Khurana, TS .
NATURE, 2002, 420 (6914) :418-421
[18]   Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure [J].
Bolger, AP ;
Sharma, R ;
von Haehling, S ;
Doehner, W ;
Oliver, B ;
Rauchhaus, M ;
Coats, AJS ;
Adcock, IM ;
Anker, SD .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (04) :384-389
[19]   RAT SKELETAL-MUSCLE METABOLISM IN EXPERIMENTAL HEART-FAILURE - EFFECTS OF PHYSICAL-TRAINING [J].
BRUNOTTE, F ;
THOMPSON, CH ;
ADAMOPOULOS, S ;
COATS, A ;
UNITT, J ;
LINDSAY, D ;
KAKLAMANIS, L ;
RADDA, GK ;
RAJAGOPALAN, B .
ACTA PHYSIOLOGICA SCANDINAVICA, 1995, 154 (04) :439-447
[20]   Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants [J].
Buck, M ;
Chojkier, M .
EMBO JOURNAL, 1996, 15 (08) :1753-1765